Bunny Twiford, RN, president of Twiford Consulting in Warminster, Pa., shares six things GI-driven ASCs should benchmark. 1. Length of the procedure vs. scheduling allotments. Ms. Twiford says ASCs ...

GI is the most common specialty in terms of case volume and the sixth most popular specialty with management companies, according to data from VMG Health and HealthCare Appraisers. Here are 32 notable ...

Please provide your email address to receive an email when new articles are posted on . GLP-1RA use prior to upper endoscopy was linked to increased risk for retained gastric contents. A 24-hour clear ...

The Endoscopy Procedures market is growing due to advancements in imaging technology, AI integration, and increased clinical applications in various domains such as GI and pulmonology. Regional ...

DUBLIN, April 11, 2019 /PRNewswire/ -- The "Gastrointestinal Endoscopic Devices Procedure Numbers - United States - 2019-2025" report has been added to ResearchAndMarkets.com's offering. GI endoscopy ...

As the effective date of UnitedHealthcare’s prior authorization policy for gastroenterology endoscopy services quickly approaches, the ACG, AGA and ASGE alongside 175 allied organizations have rallied ...

Failed sedation for routine gastrointestinal (GI) endoscopy is extremely rare, warranting a return to endoscopist-directed sedation, rather than costly anesthesia-assisted sedation, as the default ...

Dr. Kevin E. Woods is a distinguished gastroenterologist and interventional endoscopist, known for his expertise in the treatment of digestive diseases and the integration of medicine with technology.

To prepare for your appointment, we encourage you to do the following: Fill out the registration forms below and bring them with you to your appointment. Review the patient instructions prior to your ...

DUBLIN--(BUSINESS WIRE)--The "Gastrointestinal Endoscopy Devices Market: Global Industry Analysis, Trends, Market Size and Forecasts up to 2024" report has been added to ResearchAndMarkets.com's ...

DUBLIN, Nov. 15, 2021 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance ...